ATE217529T1 - Antivirale triazazyklododecane - Google Patents

Antivirale triazazyklododecane

Info

Publication number
ATE217529T1
ATE217529T1 AT96908473T AT96908473T ATE217529T1 AT E217529 T1 ATE217529 T1 AT E217529T1 AT 96908473 T AT96908473 T AT 96908473T AT 96908473 T AT96908473 T AT 96908473T AT E217529 T1 ATE217529 T1 AT E217529T1
Authority
AT
Austria
Prior art keywords
group
aromatic
independently
formula
alkyl
Prior art date
Application number
AT96908473T
Other languages
English (en)
Inventor
Thomas W Bell
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE217529T1 publication Critical patent/ATE217529T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96908473T 1995-02-17 1996-02-16 Antivirale triazazyklododecane ATE217529T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/392,550 US5663161A (en) 1995-02-17 1995-02-17 Anti-viral triaza compounds
PCT/US1996/002132 WO1996025167A1 (en) 1995-02-17 1996-02-16 Anti-viral triaza compounds

Publications (1)

Publication Number Publication Date
ATE217529T1 true ATE217529T1 (de) 2002-06-15

Family

ID=23551026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908473T ATE217529T1 (de) 1995-02-17 1996-02-16 Antivirale triazazyklododecane

Country Status (10)

Country Link
US (3) US5663161A (de)
EP (1) EP0809504B1 (de)
JP (1) JPH11500130A (de)
CN (1) CN1181013A (de)
AT (1) ATE217529T1 (de)
AU (1) AU701783B2 (de)
CA (1) CA2211920A1 (de)
DE (1) DE69621229D1 (de)
MX (1) MX9706259A (de)
WO (1) WO1996025167A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955044B1 (de) * 1995-06-26 2005-11-16 Chelator LLC Methode zur Hemmung des Wachstums von Bakterien oder Pilzen mit einem Komplexbildner
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
US20050049242A1 (en) * 2000-12-21 2005-03-03 W. Edward Robinson Novel HIV integrase inhibitors and HIV therapy based on drug combinations including integrase inhibitors
AU2002303293A1 (en) * 2001-04-06 2002-10-21 University And Community College System Of Nevada On Behalf Of The University Of Nevada, Reno Triaza compound immunoregulatory agents
US6699465B2 (en) 2001-05-18 2004-03-02 Albany Medical College Covalent attachment of polymer to cell to prevent virus bonding to receptor
JP4431959B2 (ja) * 2002-04-22 2010-03-17 ユニバーシティー オブ メリーランド，バルチモア カウンティー キャプシドタンパク質の抗ウイルス性阻害
WO2006019955A2 (en) * 2004-07-14 2006-02-23 President And Fellows Of Harvard College Antiviral methods and compositions
US20110003393A1 (en) * 2007-10-25 2011-01-06 President And Fellows Of Harvard College Systems and methods for studying influenza
JP6421652B2 (ja) * 2015-03-06 2018-11-14 横浜ゴム株式会社 空気入りタイヤ
GB2539881B (en) * 2015-06-24 2018-07-25 Advanced Risc Mach Ltd An apparatus and method for processing floating point values
CA3093972A1 (en) * 2018-03-16 2019-09-19 Kezar Life Sciences Triazacyclododecansulfonamide ("tcd")-based protein secretion inhibitors
JP2021519780A (ja) 2018-03-29 2021-08-12 ケザール ライフ サイエンシズＫｅｚａｒ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｃｄｐタンパク質分泌阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001212A (en) * 1973-10-03 1977-01-04 E. I. Du Pont De Nemours And Company Macrocyclic polyamines
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
US4994560A (en) * 1987-06-24 1991-02-19 The Dow Chemical Company Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
GB8719041D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
US5021409A (en) * 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
JP3131219B2 (ja) * 1990-01-19 2001-01-31 ニユコメド・イメージング・アクシエセルカペト キレート化合物
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
JPH0827129A (ja) 1994-07-18 1996-01-30 Rikagaku Kenkyusho 環状ポリアミン化合物及びそれを有効成分とする抗ウィルス剤

Also Published As

Publication number Publication date
WO1996025167A1 (en) 1996-08-22
US20020019423A1 (en) 2002-02-14
CA2211920A1 (en) 1996-08-22
CN1181013A (zh) 1998-05-06
US6342492B1 (en) 2002-01-29
EP0809504A1 (de) 1997-12-03
US5663161A (en) 1997-09-02
AU5170496A (en) 1996-09-04
AU701783B2 (en) 1999-02-04
EP0809504A4 (de) 1998-11-04
JPH11500130A (ja) 1999-01-06
MX9706259A (es) 1997-11-29
EP0809504B1 (de) 2002-05-15
DE69621229D1 (de) 2002-06-20

Similar Documents

Publication Publication Date Title
DE69621229D1 (de) Antivirale triazazyklododecane
DK0749437T3 (da) Farmaceutisk anvendelse af steroidderivater
FI982436A0 (fi) Kondensoituneet heterosykliset yhdisteet
IL110091A (en) POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FI955438A0 (fi) N-asyylisulfamidihappoesterit (tai -tioesterit), N-asyylisulfonamidit ja N-sulfonyylikarbamiinihappoesterit (tai -tioesterit) hyperkolesteroleemisina aineina
ATE246676T1 (de) Tetrahydrochinolinderivate mit selektive aktivität für retinoid x rezeptoren
ES2036551T3 (es) Compuestos heterociclicos.
ES2109554T3 (es) Agentes de reversion de la resistencia a multiples farmacos.
KR880013937A (ko) 옥세타노신 유도체
ATE408598T1 (de) Bicyclische verbindung
EA199900163A1 (ru) Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств
ATE122385T1 (de) Azeotrope oder azeotropähnliche zusammensetzung auf der basis von wasserstoff enthaltenden chlorfluorkohlenwasserstoffen.
DE69200394D1 (de) 3-Sulfonylamino-2-(1H)-Chinolinone und deren 7-Azaderivate als anregende Aminosäuren Antagonisten.
RU94002329A (ru) Модифицированные олигодезоксирибонуклеотиды, композиция, способ лечения и промежуточные соединения
ES2000908A6 (es) Procedimiento para la fabricacion de nuevos derivados de alquilmercaptofenil-1,3,4-oxadiazol
DE69529680D1 (de) 2',5'-phosphorthioat/phosphodiester-oligoadenylate und ihre antiviralen verwendungen
NO983527L (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
DE69319349D1 (de) Verwendung von aminen in ölzusammensetzungen
DE69007356D1 (de) Zyklisches Tetrapeptid und Verfahren zu dessen Herstellung.
CA2308315A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
BR9508979A (pt) Carboxamidas bicíclicas como antagonistas de 5-ht1a
GB2341862A (en) Histamine H3 receptor ligands
BR9405907A (pt) Heterociclos de nitrogenio substituídos e seu uso como praguicidas
DE69810294D1 (de) Calixaren-röhren als kationenrezeptoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties